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Introduction: Prostate cancer (PCa) is the second most common cancer in men worldwide 
and it is one of the leading causes of death of elderly men from malignant tumors in Kazakhstan. In 
the structure of morbidity among all malignant neoplasms, PCa occupies the 6th ranked place (5%). 
Since 2013, a screening program for the early detection of premalignant and tumor states of the 
prostate gland is being phased in the Republic of Kazakhstan. 
Methods: A database of IT named automated control system "Polyclinic" from the Pavlodar 
branch of the Republican Center for Electronic Health, a database of cancer patients from the 
Pavlodar Regional Oncology Dispensary have been analyzed. The main indicators for data 
collection have been determined: plan, performance from the plan, detectability of diseases, the 
number of detected cancers within the framework of the National Screening Program (NSP), share 
of cancer in the early and at the late stage etc. 
Results: In Pavlodar region from 2013 to 2016, 443 new cases of PCa have been identified. 
Within the framework of (NSP) in 4 years 39675 men were examined for early detection of this 
pathology, 1034 patients were identified including 91 new cases of PCa. The proportion of newly 
diagnosed cases of PCa in the NSP from the total number of newly diagnosed cases of PCa in 
Pavlodar region was 20.4%; under this program the detectability of precancerous and tumor states 
of the prostate was 2.6%, and the detectability of prostate cancer was 0.3% (according to the 
European standards, the proportion of the detected cases of PCa among the target group is 0.08%). 
The share of detected cases of PCa at an early stage was 86.8%, the late stage was 13.2%. 
Conclusion: Despite the low detectability of this pathology, it is advisable: 1) to continue the 
screening for early detection of precancerous and tumor states of the prostate, 2) to identify barriers 
and develop educational programs among the population, 3) to improve the effectiveness of the 
screening program. 
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